Cancer Stem Cells in Multiple Myeloma
Conditions
Multiple Myeloma
Conditions: official terms
Multiple Myeloma - Neoplasms, Plasma Cell
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Overall Status
Recruiting
Summary
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.
Detailed Description
The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their prognostic value and check for any relationship between cancer stem cell quantification and chemotherapy response are main aims of this study.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- New Diagnosed or Relapsed Multiple Myeloma

- Routine Bone Marrow Aspiration will be done

Exclusion Criteria:

- Bone Marrow Aspiration is not Needed
Location
Ankara University Hematology Unit
Ankara, Turkey
Status: Recruiting
Contact: Mehmet Ozen, MD - 00905362750074 - kanbilimci@gmail.com
Start Date
January 2013
Completion Date
January 2014
Sponsors
Ankara University
Source
Ankara University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page